Position in HALO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$68,223,231
+$15,442,065 QoQ
Shares Held
1,055,597
+34.6% QoQ
Ownership
0.890%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.32597383281689.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6740261671831201.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. HALO ranks #2 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,223,231 | 1,055,597 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $52,781,166 | 784,267 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $30,481,274 | 415,616 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,719,153 | 494,409 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $27,100,806 | 424,711 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,460,227 | 469,781 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $35,815,065 | 625,700 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,485,385 | 524,931 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $21,130,411 | 519,430 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,647,871 | 504,542 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $17,289,280 | 452,599 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $17,501,811 | 485,218 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $18,038,853 | 472,345 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $17,978,862 | 315,973 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $17,057,396 | 431,396 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $882,420 | 20,055 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $739,572 | 18,545 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $725,668 | 18,047 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,830,707 | 118,749 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,503,371 | 121,193 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $5,039,902 | 120,890 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $7,565,903 | 177,146 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,484,843 | 208,708 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,873,400 | 219,075 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,740,713 | 207,933 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||